Global Long-acting Reversible Contraceptives (LARCs) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Page: 138

Published Date: 24 Jan 2024

Category: Medical Devices & Consumables

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Long-acting Reversible Contraceptives (LARCs) market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

The Global Info Research report includes an overview of the development of the Long-acting Reversible Contraceptives (LARCs) industry chain, the market status of Age 20-24 (Hormonal Intrauterine Devices, Copper Intrauterine Devices), Age 25-34 (Hormonal Intrauterine Devices, Copper Intrauterine Devices), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Long-acting Reversible Contraceptives (LARCs).

Regionally, the report analyzes the Long-acting Reversible Contraceptives (LARCs) markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Long-acting Reversible Contraceptives (LARCs) market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Long-acting Reversible Contraceptives (LARCs) market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Long-acting Reversible Contraceptives (LARCs) industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Hormonal Intrauterine Devices, Copper Intrauterine Devices).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Long-acting Reversible Contraceptives (LARCs) market.

Regional Analysis: The report involves examining the Long-acting Reversible Contraceptives (LARCs) market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Long-acting Reversible Contraceptives (LARCs) market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Long-acting Reversible Contraceptives (LARCs):
Company Analysis: Report covers individual Long-acting Reversible Contraceptives (LARCs) manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Long-acting Reversible Contraceptives (LARCs) This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Age 20-24, Age 25-34).

Technology Analysis: Report covers specific technologies relevant to Long-acting Reversible Contraceptives (LARCs). It assesses the current state, advancements, and potential future developments in Long-acting Reversible Contraceptives (LARCs) areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Long-acting Reversible Contraceptives (LARCs) market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Long-acting Reversible Contraceptives (LARCs) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
    Hormonal Intrauterine Devices
    Copper Intrauterine Devices
    Contraceptive Implants
    Others

Market segment by Application
    Age 20-24
    Age 25-34
    Age 35-44
    Others

Major players covered
    Bayer
    Merck
    Cooper Companies
    AbbVie Allergan
    Yantai JiShengYaoXie
    H & J Medical
    HRA Pharma
    Pregna
    ASPIVIX
    Shanghai Dahua Pharmaceuticals
    Williams Medical Supplies
    Laboratoire 7 MED
    Durbin
    Laboratoire CCD
    Prosan
    OCON

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Long-acting Reversible Contraceptives (LARCs) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Long-acting Reversible Contraceptives (LARCs), with price, sales, revenue and global market share of Long-acting Reversible Contraceptives (LARCs) from 2019 to 2024.
Chapter 3, the Long-acting Reversible Contraceptives (LARCs) competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Long-acting Reversible Contraceptives (LARCs) breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Long-acting Reversible Contraceptives (LARCs) market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Long-acting Reversible Contraceptives (LARCs).
Chapter 14 and 15, to describe Long-acting Reversible Contraceptives (LARCs) sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Long-acting Reversible Contraceptives (LARCs)
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Long-acting Reversible Contraceptives (LARCs) Consumption Value by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Hormonal Intrauterine Devices
        1.3.3 Copper Intrauterine Devices
        1.3.4 Contraceptive Implants
        1.3.5 Others
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Long-acting Reversible Contraceptives (LARCs) Consumption Value by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Age 20-24
        1.4.3 Age 25-34
        1.4.4 Age 35-44
        1.4.5 Others
    1.5 Global Long-acting Reversible Contraceptives (LARCs) Market Size & Forecast
        1.5.1 Global Long-acting Reversible Contraceptives (LARCs) Consumption Value (2019 & 2023 & 2030)
        1.5.2 Global Long-acting Reversible Contraceptives (LARCs) Sales Quantity (2019-2030)
        1.5.3 Global Long-acting Reversible Contraceptives (LARCs) Average Price (2019-2030)

2 Manufacturers Profiles
    2.1 Bayer
        2.1.1 Bayer Details
        2.1.2 Bayer Major Business
        2.1.3 Bayer Long-acting Reversible Contraceptives (LARCs) Product and Services
        2.1.4 Bayer Long-acting Reversible Contraceptives (LARCs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Bayer Recent Developments/Updates
    2.2 Merck
        2.2.1 Merck Details
        2.2.2 Merck Major Business
        2.2.3 Merck Long-acting Reversible Contraceptives (LARCs) Product and Services
        2.2.4 Merck Long-acting Reversible Contraceptives (LARCs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Merck Recent Developments/Updates
    2.3 Cooper Companies
        2.3.1 Cooper Companies Details
        2.3.2 Cooper Companies Major Business
        2.3.3 Cooper Companies Long-acting Reversible Contraceptives (LARCs) Product and Services
        2.3.4 Cooper Companies Long-acting Reversible Contraceptives (LARCs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Cooper Companies Recent Developments/Updates
    2.4 AbbVie Allergan
        2.4.1 AbbVie Allergan Details
        2.4.2 AbbVie Allergan Major Business
        2.4.3 AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Product and Services
        2.4.4 AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 AbbVie Allergan Recent Developments/Updates
    2.5 Yantai JiShengYaoXie
        2.5.1 Yantai JiShengYaoXie Details
        2.5.2 Yantai JiShengYaoXie Major Business
        2.5.3 Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Product and Services
        2.5.4 Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Yantai JiShengYaoXie Recent Developments/Updates
    2.6 H & J Medical
        2.6.1 H & J Medical Details
        2.6.2 H & J Medical Major Business
        2.6.3 H & J Medical Long-acting Reversible Contraceptives (LARCs) Product and Services
        2.6.4 H & J Medical Long-acting Reversible Contraceptives (LARCs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 H & J Medical Recent Developments/Updates
    2.7 HRA Pharma
        2.7.1 HRA Pharma Details
        2.7.2 HRA Pharma Major Business
        2.7.3 HRA Pharma Long-acting Reversible Contraceptives (LARCs) Product and Services
        2.7.4 HRA Pharma Long-acting Reversible Contraceptives (LARCs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 HRA Pharma Recent Developments/Updates
    2.8 Pregna
        2.8.1 Pregna Details
        2.8.2 Pregna Major Business
        2.8.3 Pregna Long-acting Reversible Contraceptives (LARCs) Product and Services
        2.8.4 Pregna Long-acting Reversible Contraceptives (LARCs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 Pregna Recent Developments/Updates
    2.9 ASPIVIX
        2.9.1 ASPIVIX Details
        2.9.2 ASPIVIX Major Business
        2.9.3 ASPIVIX Long-acting Reversible Contraceptives (LARCs) Product and Services
        2.9.4 ASPIVIX Long-acting Reversible Contraceptives (LARCs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 ASPIVIX Recent Developments/Updates
    2.10 Shanghai Dahua Pharmaceuticals
        2.10.1 Shanghai Dahua Pharmaceuticals Details
        2.10.2 Shanghai Dahua Pharmaceuticals Major Business
        2.10.3 Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Product and Services
        2.10.4 Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.10.5 Shanghai Dahua Pharmaceuticals Recent Developments/Updates
    2.11 Williams Medical Supplies
        2.11.1 Williams Medical Supplies Details
        2.11.2 Williams Medical Supplies Major Business
        2.11.3 Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Product and Services
        2.11.4 Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.11.5 Williams Medical Supplies Recent Developments/Updates
    2.12 Laboratoire 7 MED
        2.12.1 Laboratoire 7 MED Details
        2.12.2 Laboratoire 7 MED Major Business
        2.12.3 Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Product and Services
        2.12.4 Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.12.5 Laboratoire 7 MED Recent Developments/Updates
    2.13 Durbin
        2.13.1 Durbin Details
        2.13.2 Durbin Major Business
        2.13.3 Durbin Long-acting Reversible Contraceptives (LARCs) Product and Services
        2.13.4 Durbin Long-acting Reversible Contraceptives (LARCs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.13.5 Durbin Recent Developments/Updates
    2.14 Laboratoire CCD
        2.14.1 Laboratoire CCD Details
        2.14.2 Laboratoire CCD Major Business
        2.14.3 Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Product and Services
        2.14.4 Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.14.5 Laboratoire CCD Recent Developments/Updates
    2.15 Prosan
        2.15.1 Prosan Details
        2.15.2 Prosan Major Business
        2.15.3 Prosan Long-acting Reversible Contraceptives (LARCs) Product and Services
        2.15.4 Prosan Long-acting Reversible Contraceptives (LARCs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.15.5 Prosan Recent Developments/Updates
    2.16 OCON
        2.16.1 OCON Details
        2.16.2 OCON Major Business
        2.16.3 OCON Long-acting Reversible Contraceptives (LARCs) Product and Services
        2.16.4 OCON Long-acting Reversible Contraceptives (LARCs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.16.5 OCON Recent Developments/Updates

3 Competitive Environment: Long-acting Reversible Contraceptives (LARCs) by Manufacturer
    3.1 Global Long-acting Reversible Contraceptives (LARCs) Sales Quantity by Manufacturer (2019-2024)
    3.2 Global Long-acting Reversible Contraceptives (LARCs) Revenue by Manufacturer (2019-2024)
    3.3 Global Long-acting Reversible Contraceptives (LARCs) Average Price by Manufacturer (2019-2024)
    3.4 Market Share Analysis (2023)
        3.4.1 Producer Shipments of Long-acting Reversible Contraceptives (LARCs) by Manufacturer Revenue ($MM) and Market Share (%): 2023
        3.4.2 Top 3 Long-acting Reversible Contraceptives (LARCs) Manufacturer Market Share in 2023
        3.4.2 Top 6 Long-acting Reversible Contraceptives (LARCs) Manufacturer Market Share in 2023
    3.5 Long-acting Reversible Contraceptives (LARCs) Market: Overall Company Footprint Analysis
        3.5.1 Long-acting Reversible Contraceptives (LARCs) Market: Region Footprint
        3.5.2 Long-acting Reversible Contraceptives (LARCs) Market: Company Product Type Footprint
        3.5.3 Long-acting Reversible Contraceptives (LARCs) Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Long-acting Reversible Contraceptives (LARCs) Market Size by Region
        4.1.1 Global Long-acting Reversible Contraceptives (LARCs) Sales Quantity by Region (2019-2030)
        4.1.2 Global Long-acting Reversible Contraceptives (LARCs) Consumption Value by Region (2019-2030)
        4.1.3 Global Long-acting Reversible Contraceptives (LARCs) Average Price by Region (2019-2030)
    4.2 North America Long-acting Reversible Contraceptives (LARCs) Consumption Value (2019-2030)
    4.3 Europe Long-acting Reversible Contraceptives (LARCs) Consumption Value (2019-2030)
    4.4 Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Consumption Value (2019-2030)
    4.5 South America Long-acting Reversible Contraceptives (LARCs) Consumption Value (2019-2030)
    4.6 Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Consumption Value (2019-2030)

5 Market Segment by Type
    5.1 Global Long-acting Reversible Contraceptives (LARCs) Sales Quantity by Type (2019-2030)
    5.2 Global Long-acting Reversible Contraceptives (LARCs) Consumption Value by Type (2019-2030)
    5.3 Global Long-acting Reversible Contraceptives (LARCs) Average Price by Type (2019-2030)

6 Market Segment by Application
    6.1 Global Long-acting Reversible Contraceptives (LARCs) Sales Quantity by Application (2019-2030)
    6.2 Global Long-acting Reversible Contraceptives (LARCs) Consumption Value by Application (2019-2030)
    6.3 Global Long-acting Reversible Contraceptives (LARCs) Average Price by Application (2019-2030)

7 North America
    7.1 North America Long-acting Reversible Contraceptives (LARCs) Sales Quantity by Type (2019-2030)
    7.2 North America Long-acting Reversible Contraceptives (LARCs) Sales Quantity by Application (2019-2030)
    7.3 North America Long-acting Reversible Contraceptives (LARCs) Market Size by Country
        7.3.1 North America Long-acting Reversible Contraceptives (LARCs) Sales Quantity by Country (2019-2030)
        7.3.2 North America Long-acting Reversible Contraceptives (LARCs) Consumption Value by Country (2019-2030)
        7.3.3 United States Market Size and Forecast (2019-2030)
        7.3.4 Canada Market Size and Forecast (2019-2030)
        7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe
    8.1 Europe Long-acting Reversible Contraceptives (LARCs) Sales Quantity by Type (2019-2030)
    8.2 Europe Long-acting Reversible Contraceptives (LARCs) Sales Quantity by Application (2019-2030)
    8.3 Europe Long-acting Reversible Contraceptives (LARCs) Market Size by Country
        8.3.1 Europe Long-acting Reversible Contraceptives (LARCs) Sales Quantity by Country (2019-2030)
        8.3.2 Europe Long-acting Reversible Contraceptives (LARCs) Consumption Value by Country (2019-2030)
        8.3.3 Germany Market Size and Forecast (2019-2030)
        8.3.4 France Market Size and Forecast (2019-2030)
        8.3.5 United Kingdom Market Size and Forecast (2019-2030)
        8.3.6 Russia Market Size and Forecast (2019-2030)
        8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific
    9.1 Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales Quantity by Type (2019-2030)
    9.2 Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales Quantity by Application (2019-2030)
    9.3 Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Market Size by Region
        9.3.1 Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales Quantity by Region (2019-2030)
        9.3.2 Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Consumption Value by Region (2019-2030)
        9.3.3 China Market Size and Forecast (2019-2030)
        9.3.4 Japan Market Size and Forecast (2019-2030)
        9.3.5 Korea Market Size and Forecast (2019-2030)
        9.3.6 India Market Size and Forecast (2019-2030)
        9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
        9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America
    10.1 South America Long-acting Reversible Contraceptives (LARCs) Sales Quantity by Type (2019-2030)
    10.2 South America Long-acting Reversible Contraceptives (LARCs) Sales Quantity by Application (2019-2030)
    10.3 South America Long-acting Reversible Contraceptives (LARCs) Market Size by Country
        10.3.1 South America Long-acting Reversible Contraceptives (LARCs) Sales Quantity by Country (2019-2030)
        10.3.2 South America Long-acting Reversible Contraceptives (LARCs) Consumption Value by Country (2019-2030)
        10.3.3 Brazil Market Size and Forecast (2019-2030)
        10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa
    11.1 Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Sales Quantity by Type (2019-2030)
    11.2 Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Sales Quantity by Application (2019-2030)
    11.3 Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Market Size by Country
        11.3.1 Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Sales Quantity by Country (2019-2030)
        11.3.2 Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Consumption Value by Country (2019-2030)
        11.3.3 Turkey Market Size and Forecast (2019-2030)
        11.3.4 Egypt Market Size and Forecast (2019-2030)
        11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
        11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics
    12.1 Long-acting Reversible Contraceptives (LARCs) Market Drivers
    12.2 Long-acting Reversible Contraceptives (LARCs) Market Restraints
    12.3 Long-acting Reversible Contraceptives (LARCs) Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
    13.1 Raw Material of Long-acting Reversible Contraceptives (LARCs) and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Long-acting Reversible Contraceptives (LARCs)
    13.3 Long-acting Reversible Contraceptives (LARCs) Production Process
    13.4 Long-acting Reversible Contraceptives (LARCs) Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Long-acting Reversible Contraceptives (LARCs) Typical Distributors
    14.3 Long-acting Reversible Contraceptives (LARCs) Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Long-acting Reversible Contraceptives (LARCs) Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Long-acting Reversible Contraceptives (LARCs) Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Bayer Basic Information, Manufacturing Base and Competitors
    Table 4. Bayer Major Business
    Table 5. Bayer Long-acting Reversible Contraceptives (LARCs) Product and Services
    Table 6. Bayer Long-acting Reversible Contraceptives (LARCs) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 7. Bayer Recent Developments/Updates
    Table 8. Merck Basic Information, Manufacturing Base and Competitors
    Table 9. Merck Major Business
    Table 10. Merck Long-acting Reversible Contraceptives (LARCs) Product and Services
    Table 11. Merck Long-acting Reversible Contraceptives (LARCs) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 12. Merck Recent Developments/Updates
    Table 13. Cooper Companies Basic Information, Manufacturing Base and Competitors
    Table 14. Cooper Companies Major Business
    Table 15. Cooper Companies Long-acting Reversible Contraceptives (LARCs) Product and Services
    Table 16. Cooper Companies Long-acting Reversible Contraceptives (LARCs) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 17. Cooper Companies Recent Developments/Updates
    Table 18. AbbVie Allergan Basic Information, Manufacturing Base and Competitors
    Table 19. AbbVie Allergan Major Business
    Table 20. AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Product and Services
    Table 21. AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 22. AbbVie Allergan Recent Developments/Updates
    Table 23. Yantai JiShengYaoXie Basic Information, Manufacturing Base and Competitors
    Table 24. Yantai JiShengYaoXie Major Business
    Table 25. Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Product and Services
    Table 26. Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 27. Yantai JiShengYaoXie Recent Developments/Updates
    Table 28. H & J Medical Basic Information, Manufacturing Base and Competitors
    Table 29. H & J Medical Major Business
    Table 30. H & J Medical Long-acting Reversible Contraceptives (LARCs) Product and Services
    Table 31. H & J Medical Long-acting Reversible Contraceptives (LARCs) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 32. H & J Medical Recent Developments/Updates
    Table 33. HRA Pharma Basic Information, Manufacturing Base and Competitors
    Table 34. HRA Pharma Major Business
    Table 35. HRA Pharma Long-acting Reversible Contraceptives (LARCs) Product and Services
    Table 36. HRA Pharma Long-acting Reversible Contraceptives (LARCs) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 37. HRA Pharma Recent Developments/Updates
    Table 38. Pregna Basic Information, Manufacturing Base and Competitors
    Table 39. Pregna Major Business
    Table 40. Pregna Long-acting Reversible Contraceptives (LARCs) Product and Services
    Table 41. Pregna Long-acting Reversible Contraceptives (LARCs) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 42. Pregna Recent Developments/Updates
    Table 43. ASPIVIX Basic Information, Manufacturing Base and Competitors
    Table 44. ASPIVIX Major Business
    Table 45. ASPIVIX Long-acting Reversible Contraceptives (LARCs) Product and Services
    Table 46. ASPIVIX Long-acting Reversible Contraceptives (LARCs) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 47. ASPIVIX Recent Developments/Updates
    Table 48. Shanghai Dahua Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 49. Shanghai Dahua Pharmaceuticals Major Business
    Table 50. Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Product and Services
    Table 51. Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 52. Shanghai Dahua Pharmaceuticals Recent Developments/Updates
    Table 53. Williams Medical Supplies Basic Information, Manufacturing Base and Competitors
    Table 54. Williams Medical Supplies Major Business
    Table 55. Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Product and Services
    Table 56. Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 57. Williams Medical Supplies Recent Developments/Updates
    Table 58. Laboratoire 7 MED Basic Information, Manufacturing Base and Competitors
    Table 59. Laboratoire 7 MED Major Business
    Table 60. Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Product and Services
    Table 61. Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 62. Laboratoire 7 MED Recent Developments/Updates
    Table 63. Durbin Basic Information, Manufacturing Base and Competitors
    Table 64. Durbin Major Business
    Table 65. Durbin Long-acting Reversible Contraceptives (LARCs) Product and Services
    Table 66. Durbin Long-acting Reversible Contraceptives (LARCs) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 67. Durbin Recent Developments/Updates
    Table 68. Laboratoire CCD Basic Information, Manufacturing Base and Competitors
    Table 69. Laboratoire CCD Major Business
    Table 70. Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Product and Services
    Table 71. Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 72. Laboratoire CCD Recent Developments/Updates
    Table 73. Prosan Basic Information, Manufacturing Base and Competitors
    Table 74. Prosan Major Business
    Table 75. Prosan Long-acting Reversible Contraceptives (LARCs) Product and Services
    Table 76. Prosan Long-acting Reversible Contraceptives (LARCs) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 77. Prosan Recent Developments/Updates
    Table 78. OCON Basic Information, Manufacturing Base and Competitors
    Table 79. OCON Major Business
    Table 80. OCON Long-acting Reversible Contraceptives (LARCs) Product and Services
    Table 81. OCON Long-acting Reversible Contraceptives (LARCs) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 82. OCON Recent Developments/Updates
    Table 83. Global Long-acting Reversible Contraceptives (LARCs) Sales Quantity by Manufacturer (2019-2024) & (K Units)
    Table 84. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Manufacturer (2019-2024) & (USD Million)
    Table 85. Global Long-acting Reversible Contraceptives (LARCs) Average Price by Manufacturer (2019-2024) & (US$/Unit)
    Table 86. Market Position of Manufacturers in Long-acting Reversible Contraceptives (LARCs), (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
    Table 87. Head Office and Long-acting Reversible Contraceptives (LARCs) Production Site of Key Manufacturer
    Table 88. Long-acting Reversible Contraceptives (LARCs) Market: Company Product Type Footprint
    Table 89. Long-acting Reversible Contraceptives (LARCs) Market: Company Product Application Footprint
    Table 90. Long-acting Reversible Contraceptives (LARCs) New Market Entrants and Barriers to Market Entry
    Table 91. Long-acting Reversible Contraceptives (LARCs) Mergers, Acquisition, Agreements, and Collaborations
    Table 92. Global Long-acting Reversible Contraceptives (LARCs) Sales Quantity by Region (2019-2024) & (K Units)
    Table 93. Global Long-acting Reversible Contraceptives (LARCs) Sales Quantity by Region (2025-2030) & (K Units)
    Table 94. Global Long-acting Reversible Contraceptives (LARCs) Consumption Value by Region (2019-2024) & (USD Million)
    Table 95. Global Long-acting Reversible Contraceptives (LARCs) Consumption Value by Region (2025-2030) & (USD Million)
    Table 96. Global Long-acting Reversible Contraceptives (LARCs) Average Price by Region (2019-2024) & (US$/Unit)
    Table 97. Global Long-acting Reversible Contraceptives (LARCs) Average Price by Region (2025-2030) & (US$/Unit)
    Table 98. Global Long-acting Reversible Contraceptives (LARCs) Sales Quantity by Type (2019-2024) & (K Units)
    Table 99. Global Long-acting Reversible Contraceptives (LARCs) Sales Quantity by Type (2025-2030) & (K Units)
    Table 100. Global Long-acting Reversible Contraceptives (LARCs) Consumption Value by Type (2019-2024) & (USD Million)
    Table 101. Global Long-acting Reversible Contraceptives (LARCs) Consumption Value by Type (2025-2030) & (USD Million)
    Table 102. Global Long-acting Reversible Contraceptives (LARCs) Average Price by Type (2019-2024) & (US$/Unit)
    Table 103. Global Long-acting Reversible Contraceptives (LARCs) Average Price by Type (2025-2030) & (US$/Unit)
    Table 104. Global Long-acting Reversible Contraceptives (LARCs) Sales Quantity by Application (2019-2024) & (K Units)
    Table 105. Global Long-acting Reversible Contraceptives (LARCs) Sales Quantity by Application (2025-2030) & (K Units)
    Table 106. Global Long-acting Reversible Contraceptives (LARCs) Consumption Value by Application (2019-2024) & (USD Million)
    Table 107. Global Long-acting Reversible Contraceptives (LARCs) Consumption Value by Application (2025-2030) & (USD Million)
    Table 108. Global Long-acting Reversible Contraceptives (LARCs) Average Price by Application (2019-2024) & (US$/Unit)
    Table 109. Global Long-acting Reversible Contraceptives (LARCs) Average Price by Application (2025-2030) & (US$/Unit)
    Table 110. North America Long-acting Reversible Contraceptives (LARCs) Sales Quantity by Type (2019-2024) & (K Units)
    Table 111. North America Long-acting Reversible Contraceptives (LARCs) Sales Quantity by Type (2025-2030) & (K Units)
    Table 112. North America Long-acting Reversible Contraceptives (LARCs) Sales Quantity by Application (2019-2024) & (K Units)
    Table 113. North America Long-acting Reversible Contraceptives (LARCs) Sales Quantity by Application (2025-2030) & (K Units)
    Table 114. North America Long-acting Reversible Contraceptives (LARCs) Sales Quantity by Country (2019-2024) & (K Units)
    Table 115. North America Long-acting Reversible Contraceptives (LARCs) Sales Quantity by Country (2025-2030) & (K Units)
    Table 116. North America Long-acting Reversible Contraceptives (LARCs) Consumption Value by Country (2019-2024) & (USD Million)
    Table 117. North America Long-acting Reversible Contraceptives (LARCs) Consumption Value by Country (2025-2030) & (USD Million)
    Table 118. Europe Long-acting Reversible Contraceptives (LARCs) Sales Quantity by Type (2019-2024) & (K Units)
    Table 119. Europe Long-acting Reversible Contraceptives (LARCs) Sales Quantity by Type (2025-2030) & (K Units)
    Table 120. Europe Long-acting Reversible Contraceptives (LARCs) Sales Quantity by Application (2019-2024) & (K Units)
    Table 121. Europe Long-acting Reversible Contraceptives (LARCs) Sales Quantity by Application (2025-2030) & (K Units)
    Table 122. Europe Long-acting Reversible Contraceptives (LARCs) Sales Quantity by Country (2019-2024) & (K Units)
    Table 123. Europe Long-acting Reversible Contraceptives (LARCs) Sales Quantity by Country (2025-2030) & (K Units)
    Table 124. Europe Long-acting Reversible Contraceptives (LARCs) Consumption Value by Country (2019-2024) & (USD Million)
    Table 125. Europe Long-acting Reversible Contraceptives (LARCs) Consumption Value by Country (2025-2030) & (USD Million)
    Table 126. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales Quantity by Type (2019-2024) & (K Units)
    Table 127. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales Quantity by Type (2025-2030) & (K Units)
    Table 128. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales Quantity by Application (2019-2024) & (K Units)
    Table 129. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales Quantity by Application (2025-2030) & (K Units)
    Table 130. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales Quantity by Region (2019-2024) & (K Units)
    Table 131. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales Quantity by Region (2025-2030) & (K Units)
    Table 132. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Consumption Value by Region (2019-2024) & (USD Million)
    Table 133. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Consumption Value by Region (2025-2030) & (USD Million)
    Table 134. South America Long-acting Reversible Contraceptives (LARCs) Sales Quantity by Type (2019-2024) & (K Units)
    Table 135. South America Long-acting Reversible Contraceptives (LARCs) Sales Quantity by Type (2025-2030) & (K Units)
    Table 136. South America Long-acting Reversible Contraceptives (LARCs) Sales Quantity by Application (2019-2024) & (K Units)
    Table 137. South America Long-acting Reversible Contraceptives (LARCs) Sales Quantity by Application (2025-2030) & (K Units)
    Table 138. South America Long-acting Reversible Contraceptives (LARCs) Sales Quantity by Country (2019-2024) & (K Units)
    Table 139. South America Long-acting Reversible Contraceptives (LARCs) Sales Quantity by Country (2025-2030) & (K Units)
    Table 140. South America Long-acting Reversible Contraceptives (LARCs) Consumption Value by Country (2019-2024) & (USD Million)
    Table 141. South America Long-acting Reversible Contraceptives (LARCs) Consumption Value by Country (2025-2030) & (USD Million)
    Table 142. Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Sales Quantity by Type (2019-2024) & (K Units)
    Table 143. Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Sales Quantity by Type (2025-2030) & (K Units)
    Table 144. Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Sales Quantity by Application (2019-2024) & (K Units)
    Table 145. Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Sales Quantity by Application (2025-2030) & (K Units)
    Table 146. Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Sales Quantity by Region (2019-2024) & (K Units)
    Table 147. Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Sales Quantity by Region (2025-2030) & (K Units)
    Table 148. Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Consumption Value by Region (2019-2024) & (USD Million)
    Table 149. Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Consumption Value by Region (2025-2030) & (USD Million)
    Table 150. Long-acting Reversible Contraceptives (LARCs) Raw Material
    Table 151. Key Manufacturers of Long-acting Reversible Contraceptives (LARCs) Raw Materials
    Table 152. Long-acting Reversible Contraceptives (LARCs) Typical Distributors
    Table 153. Long-acting Reversible Contraceptives (LARCs) Typical Customers
List of Figures
    Figure 1. Long-acting Reversible Contraceptives (LARCs) Picture
    Figure 2. Global Long-acting Reversible Contraceptives (LARCs) Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Long-acting Reversible Contraceptives (LARCs) Consumption Value Market Share by Type in 2023
    Figure 4. Hormonal Intrauterine Devices Examples
    Figure 5. Copper Intrauterine Devices Examples
    Figure 6. Contraceptive Implants Examples
    Figure 7. Others Examples
    Figure 8. Global Long-acting Reversible Contraceptives (LARCs) Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Figure 9. Global Long-acting Reversible Contraceptives (LARCs) Consumption Value Market Share by Application in 2023
    Figure 10. Age 20-24 Examples
    Figure 11. Age 25-34 Examples
    Figure 12. Age 35-44 Examples
    Figure 13. Others Examples
    Figure 14. Global Long-acting Reversible Contraceptives (LARCs) Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 15. Global Long-acting Reversible Contraceptives (LARCs) Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 16. Global Long-acting Reversible Contraceptives (LARCs) Sales Quantity (2019-2030) & (K Units)
    Figure 17. Global Long-acting Reversible Contraceptives (LARCs) Average Price (2019-2030) & (US$/Unit)
    Figure 18. Global Long-acting Reversible Contraceptives (LARCs) Sales Quantity Market Share by Manufacturer in 2023
    Figure 19. Global Long-acting Reversible Contraceptives (LARCs) Consumption Value Market Share by Manufacturer in 2023
    Figure 20. Producer Shipments of Long-acting Reversible Contraceptives (LARCs) by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
    Figure 21. Top 3 Long-acting Reversible Contraceptives (LARCs) Manufacturer (Consumption Value) Market Share in 2023
    Figure 22. Top 6 Long-acting Reversible Contraceptives (LARCs) Manufacturer (Consumption Value) Market Share in 2023
    Figure 23. Global Long-acting Reversible Contraceptives (LARCs) Sales Quantity Market Share by Region (2019-2030)
    Figure 24. Global Long-acting Reversible Contraceptives (LARCs) Consumption Value Market Share by Region (2019-2030)
    Figure 25. North America Long-acting Reversible Contraceptives (LARCs) Consumption Value (2019-2030) & (USD Million)
    Figure 26. Europe Long-acting Reversible Contraceptives (LARCs) Consumption Value (2019-2030) & (USD Million)
    Figure 27. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Consumption Value (2019-2030) & (USD Million)
    Figure 28. South America Long-acting Reversible Contraceptives (LARCs) Consumption Value (2019-2030) & (USD Million)
    Figure 29. Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Consumption Value (2019-2030) & (USD Million)
    Figure 30. Global Long-acting Reversible Contraceptives (LARCs) Sales Quantity Market Share by Type (2019-2030)
    Figure 31. Global Long-acting Reversible Contraceptives (LARCs) Consumption Value Market Share by Type (2019-2030)
    Figure 32. Global Long-acting Reversible Contraceptives (LARCs) Average Price by Type (2019-2030) & (US$/Unit)
    Figure 33. Global Long-acting Reversible Contraceptives (LARCs) Sales Quantity Market Share by Application (2019-2030)
    Figure 34. Global Long-acting Reversible Contraceptives (LARCs) Consumption Value Market Share by Application (2019-2030)
    Figure 35. Global Long-acting Reversible Contraceptives (LARCs) Average Price by Application (2019-2030) & (US$/Unit)
    Figure 36. North America Long-acting Reversible Contraceptives (LARCs) Sales Quantity Market Share by Type (2019-2030)
    Figure 37. North America Long-acting Reversible Contraceptives (LARCs) Sales Quantity Market Share by Application (2019-2030)
    Figure 38. North America Long-acting Reversible Contraceptives (LARCs) Sales Quantity Market Share by Country (2019-2030)
    Figure 39. North America Long-acting Reversible Contraceptives (LARCs) Consumption Value Market Share by Country (2019-2030)
    Figure 40. United States Long-acting Reversible Contraceptives (LARCs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 41. Canada Long-acting Reversible Contraceptives (LARCs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 42. Mexico Long-acting Reversible Contraceptives (LARCs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 43. Europe Long-acting Reversible Contraceptives (LARCs) Sales Quantity Market Share by Type (2019-2030)
    Figure 44. Europe Long-acting Reversible Contraceptives (LARCs) Sales Quantity Market Share by Application (2019-2030)
    Figure 45. Europe Long-acting Reversible Contraceptives (LARCs) Sales Quantity Market Share by Country (2019-2030)
    Figure 46. Europe Long-acting Reversible Contraceptives (LARCs) Consumption Value Market Share by Country (2019-2030)
    Figure 47. Germany Long-acting Reversible Contraceptives (LARCs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 48. France Long-acting Reversible Contraceptives (LARCs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 49. United Kingdom Long-acting Reversible Contraceptives (LARCs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 50. Russia Long-acting Reversible Contraceptives (LARCs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 51. Italy Long-acting Reversible Contraceptives (LARCs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 52. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales Quantity Market Share by Type (2019-2030)
    Figure 53. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales Quantity Market Share by Application (2019-2030)
    Figure 54. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales Quantity Market Share by Region (2019-2030)
    Figure 55. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Consumption Value Market Share by Region (2019-2030)
    Figure 56. China Long-acting Reversible Contraceptives (LARCs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 57. Japan Long-acting Reversible Contraceptives (LARCs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 58. Korea Long-acting Reversible Contraceptives (LARCs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 59. India Long-acting Reversible Contraceptives (LARCs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 60. Southeast Asia Long-acting Reversible Contraceptives (LARCs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 61. Australia Long-acting Reversible Contraceptives (LARCs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 62. South America Long-acting Reversible Contraceptives (LARCs) Sales Quantity Market Share by Type (2019-2030)
    Figure 63. South America Long-acting Reversible Contraceptives (LARCs) Sales Quantity Market Share by Application (2019-2030)
    Figure 64. South America Long-acting Reversible Contraceptives (LARCs) Sales Quantity Market Share by Country (2019-2030)
    Figure 65. South America Long-acting Reversible Contraceptives (LARCs) Consumption Value Market Share by Country (2019-2030)
    Figure 66. Brazil Long-acting Reversible Contraceptives (LARCs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 67. Argentina Long-acting Reversible Contraceptives (LARCs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 68. Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Sales Quantity Market Share by Type (2019-2030)
    Figure 69. Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Sales Quantity Market Share by Application (2019-2030)
    Figure 70. Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Sales Quantity Market Share by Region (2019-2030)
    Figure 71. Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Consumption Value Market Share by Region (2019-2030)
    Figure 72. Turkey Long-acting Reversible Contraceptives (LARCs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 73. Egypt Long-acting Reversible Contraceptives (LARCs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 74. Saudi Arabia Long-acting Reversible Contraceptives (LARCs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 75. South Africa Long-acting Reversible Contraceptives (LARCs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 76. Long-acting Reversible Contraceptives (LARCs) Market Drivers
    Figure 77. Long-acting Reversible Contraceptives (LARCs) Market Restraints
    Figure 78. Long-acting Reversible Contraceptives (LARCs) Market Trends
    Figure 79. Porters Five Forces Analysis
    Figure 80. Manufacturing Cost Structure Analysis of Long-acting Reversible Contraceptives (LARCs) in 2023
    Figure 81. Manufacturing Process Analysis of Long-acting Reversible Contraceptives (LARCs)
    Figure 82. Long-acting Reversible Contraceptives (LARCs) Industrial Chain
    Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 84. Direct Channel Pros & Cons
    Figure 85. Indirect Channel Pros & Cons
    Figure 86. Methodology
    Figure 87. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Bayer
Merck
Cooper Companies
AbbVie Allergan
Yantai JiShengYaoXie
H & J Medical
HRA Pharma
Pregna
ASPIVIX
Shanghai Dahua Pharmaceuticals
Williams Medical Supplies
Laboratoire 7 MED
Durbin
Laboratoire CCD
Prosan
OCON

Related Reports

Global Long-acting Reversible Contraceptives (LARCs) Supply, Demand and Key Producers, 2023-2029

Global Long-acting Reversible Contraceptives (LARCs) Supply, Demand and Key Producers, 2023-2029

date 05 Feb 2023

date Medical Devices & Consumables

The global Long-acting Reversible Contraceptives (LARCs) market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Long-acting Reversible Contraceptives (LARCs) Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Long-acting Reversible Contraceptives (LARCs) Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 04 Jan 2023

date Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Long-acting Reversible Contraceptives (LARCs) market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Product Tags

long acting reversible contraceptives larcs

Long-acting Reversible Contraceptives (LARCs)

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>